Literature DB >> 9055211

International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.

C Herrmann1.   

Abstract

More than 200 published studies from most medical settings worldwide have reported experiences with the Hospital Anxiety and Depression Scale (HADS) which was specifically developed by Zigmond and Snaith for use with physically ill patients. Although introduced in 1983, there is still no comprehensive documentation of its psychometric properties. The present review summarizes available data on reliability and validity and gives an overview of clinical studies conducted with this instrument and their most important findings. The HADS gives clinically meaningful results as a psychological screening tool, in clinical group comparisons and in correlational studies with several aspects of disease and quality of life. It is sensitive to changes both during the course of diseases and in response to psychotherapeutic and psychopharmacological intervention. Finally, HADS scores predict psychosocial and possibly also physical outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9055211     DOI: 10.1016/s0022-3999(96)00216-4

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  563 in total

1.  Does psychological status predict the presentation in primary care of women with a menstrual disturbance?

Authors:  M Shapley; P R Croft; R McCarney; M Lewis
Journal:  Br J Gen Pract       Date:  2000-06       Impact factor: 5.386

2.  [Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population].

Authors:  D Freier; M Englbrecht; V Höhne-Zimmer; J Detert; G-R Burmester
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

3.  Fatigue: a prevalent symptom in gastroparesis.

Authors:  Dinu Cherian; Susmita Paladugu; Murali Pathikonda; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2012-06-05       Impact factor: 3.199

4.  Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study.

Authors:  M T E Puts; J Monette; V Girre; C Wolfson; M Monette; G Batist; H Bergman
Journal:  Ann Oncol       Date:  2010-10-05       Impact factor: 32.976

5.  Using and interpreting mental health measures in the National Social Life, Health, and Aging Project.

Authors:  Carolyn Payne; E C Hedberg; Michael Kozloski; William Dale; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

6.  Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study.

Authors:  Oscar J Bienvenu; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Victor D Dinglas; Carl Shanholtz; Nadia Husain; Cheryl R Dennison; Margaret S Herridge; Peter J Pronovost; Dale M Needham
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

Review 7.  Starting insulin therapy in elderly patients.

Authors:  T J Hendra
Journal:  J R Soc Med       Date:  2002-09       Impact factor: 5.344

8.  Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV.

Authors:  Salvador Cabrera Figueroa; Alicia Iglesias Gómez; Almudena Sánchez Martín; María de la Paz Valverde Merino; Alfonso Domínguez-Gil Hurlé; Miguel Cordero Sánchez
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

9.  Children and Employment - Resource or Stressors after Breast Cancer?

Authors:  K Ebenhan; K Leuteritz; Y Barthel; M E Beutel; K Papsdorf; G Weissflog; E Brähler
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-08       Impact factor: 2.915

10.  The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability.

Authors:  Kyriaki Mystakidou; Eleni Tsilika; Efi Parpa; Emmanuela Katsouda; Antonis Galanos; Lambros Vlahos
Journal:  Support Care Cancer       Date:  2004-10-06       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.